Bio Behavioral Health

What Bio Behavioral Health does

Bio Behavioral Health (BBH) is a private, founder-operated clinical research site headquartered at 20 Hospital Drive, Suite 12, Toms River, New Jersey. Founded in 1997 by Dr. Ashok Patel, a Cornell-trained geriatric psychiatrist with over 30 years of practice, the firm runs Phase III and IV clinical trials in neuropsychiatric and CNS conditions including depression, bipolar disorder, anxiety, PTSD, migraines, OCD, Parkinson's disease, and Alzheimer's disease. The site operates a single physical location supplemented by the Memory and Aging Center of New Jersey, a sub-brand dedicated to memory-loss treatment and Alzheimer's and Parkinson's research built on more than 20 years of BBH's accumulated memory-related trial experience.

BBH serves two principal customer segments: adult patients with neuropsychiatric conditions seeking access to investigational therapies, and pharmaceutical and biotech sponsors requiring community-based research sites with proven enrollment performance in CNS indications. Patient recruitment is community-led, driven by local healthcare provider referrals built over Dr. Patel's clinical practice, a website with disease-specific landing pages, and Google Forms-based free phone evaluations. The firm has completed over 200 clinical trials to date and now participates in PhaseWell Research's national multisite network, a partnership announced in January 2026 that expands BBH's sponsor pipeline and geographic reach.

Revenue is generated through professional-services clinical trial contracts with pharmaceutical and biotech sponsors, paid as per-enrolled-participant research fees. Treatments are provided at no cost to participants and travel funds are offered, so the consumer-facing pricing model is non-monetary. The firm's competitive position rests primarily on Dr. Patel's principal-investigator credentials and his long-tenured referral relationships in the Toms River community, rather than on proprietary technology, AI capability, or scaled infrastructure.

Name

Bio Behavioral Health

Legal name

Bio Behavioral Health

Website

https://biobehavioralhealth.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Bio Behavioral Health is a private, single-site clinical research organization in Toms River, New Jersey, founded in 1997 by Dr. Ashok Patel. It conducts Phase III and IV neuropsychiatric and CNS trials for pharmaceutical and biotech sponsors, serving adult patients with depression, anxiety, PTSD, Alzheimer's, Parkinson's, and related conditions.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Residential Mental Health Treatment Centers (HLAFACAC)

akta.pro secondary industries

Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH), Dementia/Alzheimer’s Care Management & Behavioral Support (HLADALAF)

Keywords

• Clinical research services
• Psychiatric clinical trials
• Neuropsychiatric research
• Clinical trial site
• CNS clinical trials

Headquarters

HQ city

Toms River

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Sponsorship: Revenue generated from pharmaceutical and biotech companies sponsoring clinical trials. BBH serves as a research site, conducting trials on behalf of sponsors in exchange for research fees per enrolled participant.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Bio Behavioral Health is a full-service clinical research site specializing in psychiatry, conducting Phase III and IV treatment trials for depression, bipolar disorder, anxiety, PTSD, migraines, OCD, Parkinson's Disease, and Alzheimer's Disease. It enrolls community-based patients in pharmaceutical-sponsored trials and also operates the Memory and Aging Center of New Jersey, a specialized center providing memory evaluations and research participation for Alzheimer's and Parkinson's patients.

Product overview

Bio Behavioral Health operates as a comprehensive clinical research organization specializing in psychiatry, comprising a core clinical research site directed by Dr. Ashok Patel, a specialized Memory and Aging Center of New Jersey, and an online platform for patient recruitment into active clinical trials. The company offers direct clinical trial services for conditions including depression, bipolar disorder, anxiety, PTSD, migraines, Parkinson's Disease, and Alzheimer's Disease. Through its partnership with PhaseWell Research, BBH participates in a national network providing access to next-generation CNS therapeutics in community settings, with over 200 completed clinical trials to date.

Differentiator

Problem solved

Functional benefit

Brands

• Memory and Aging Center of New Jersey: A specialized center established by Dr. Ashok Patel to provide treatment and support for those affected by memory loss, including Alzheimer's Disease and Parkinson's Disease.

Products and services

• Bio Behavioral Health Clinical Research Site A full-service clinical research site directed by Dr. Ashok Patel in Toms River, NJ that conducts Phase III and IV treatment trials for psychiatric and neurologic disorders including depression, bipolar, anxiety, PTSD, migraines, OCD, Parkinson's Disease, and Alzheimer's Disease on behalf of pharmaceutical and biotech sponsors.
• Memory and Aging Center of New Jersey A specialized center established by Dr. Patel providing thorough memory evaluations at no cost and conducting clinical trials for Alzheimer's Disease and Parkinson's Disease, offering treatment and support for those affected by memory loss in the local community and beyond.
• Clinical Trial Services

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• PhaseWell ResearchcoreStrategic or Co-development Partner · 21 January 2026PhaseWell Research partnered with Bio Behavioral Health to expand access to neuropsychiatric and CNS clinical trials across the United States. BBH brings over 200 completed clinical trials and expertise in psychiatric and neurologic disorders to PhaseWell's national network. The combined entity leverages PhaseWell's platform of more than 1,800 completed trials and 150 therapy approvals to improve patient access to next-generation CNS therapeutics in community settings. Both BBH founder Dr. Ashok Patel and PhaseWell CEO Carsten Bick emphasized that the partnership addresses the growing unmet need in neuropsychiatric disorders.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Worldwide Clinical Trials: Mid-to-large global CRO with a strong CNS and neuroscience therapeutic area; a relevant scaled comparator for neuropsychiatric trial delivery.
• Elligo Health Research: Large site-management organization that runs clinical trials in community healthcare settings, including CNS; a scaled incumbent whose Research Ready model overlaps with BBH's community-based research positioning.
• IQVIA: Largest global CRO with a dedicated CNS therapeutic area and broad site network; competes for the same Phase III/IV psychiatry and neurology sponsor contracts at a much larger scale.
• Syneos Health: Global biopharmaceutical services organization with a Clinical Solutions site network and CNS delivery capability; a scaled incumbent competing for the same sponsor study awards.
• Parexel: Global CRO with significant CNS and neurology trial delivery experience; a broad incumbent that sponsors may use instead of small community sites for neuropsychiatric Phase III/IV studies.

Direct peers

• PhaseWell Research: National multisite clinical research network that BBH joined in January 2026; runs community-based CNS/neuropsychiatric trials at scale, the most directly comparable operating model to BBH.
• Hassman Research Institute: Independent clinical research site in New Jersey running Phase II-IV psychiatric and CNS trials; comparable single-site psych CRO model competing for the same sponsor work.
• CNS Healthcare: Multi-site clinical research organization specializing in psychiatry, neurology, and CNS trials; directly comparable therapeutic focus and community-site delivery model.
• Atlanta Center for Medical Research: Independent psychiatric and CNS clinical research site running Phase II-IV trials; comparable single-site psych research operator with a strong PI-led model.

Emerging players

• CliniOps: Digital clinical trial technology and decentralized trial provider; thematically adjacent as a tech-enabled participant in modern CNS trial delivery and recruitment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/biobehavioralhe
• LinkedInlinkedin.com/company/biobehavioral-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio Behavioral Health